HER2, AR protein expression and chromosomal instability in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)

被引：0
|
作者：
Ontiveros, Priscilla [1 ]
Landaverde, Connie [1 ]
Levin, Maren K. [2 ]
Hippely, Sarah [2 ]
Landers, Mark [1 ]
Wang, Yipeng [1 ]
Dittamore, Ryan [1 ]
O'Shaughnessy, Joyce A. [2 ]
机构：
[1] Epic Sci, San Diego, CA USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
457
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
    Gradilone, A.
    Naso, G.
    Raimondi, C.
    Cortesi, E.
    Gandini, O.
    Vincenzi, B.
    Saltarelli, R.
    Chiapparino, E.
    Spremberg, F.
    Cristofanilli, M.
    Frati, L.
    Agliano, A. M.
    Gazzaniga, P.
    ANNALS OF ONCOLOGY, 2011, 22 (01) : 86 - 92
  • [42] Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer
    Woestemeier, Anna
    Ghadban, Tarik
    Riethdorf, Sabine
    Harms-Effenberger, Katharina
    Konczalla, Leonie
    Uzunoglu, Faik G.
    Izbicki, Jakob R.
    Pantel, Klaus
    Bockhorn, Maximilian
    Reeh, Matthias
    ANTICANCER RESEARCH, 2018, 38 (10) : 5665 - 5669
  • [43] Prognostic Value of Circulating Tumor Cells (CTC) in HER-2 Positive Metastatic Breast Cancer (MBC) Patients (pts) Treated with Anti-HER2-Based Therapy
    Giuliano, M.
    Giordano, A.
    Handy, B. C.
    Ueno, N. T.
    Alvarez, R. H.
    Hortobagyi, G. N.
    Reuben, J. M.
    Valero, V.
    Cristofanilli, M.
    CANCER RESEARCH, 2010, 70
  • [44] Evaluation of HER-2 status on circulating tumor cells (CTCS) in patients with breast cancer
    Pestrin, M.
    Bessi, S.
    Truglia, M.
    Galardi, F.
    Cappadona, S.
    Biagioni, C.
    Claudino, W.
    Pozzessere, D.
    Biganzoli, L.
    Giannini, A.
    Di Leo, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 44 - 44
  • [45] Apoptotic Circulating Tumor Cells (CTCs) in early and metastatic breast cancer patients
    Kallergi, Galatea
    Konstantinidis, Georgios
    Papadaki, Maria
    Agelaki, Sophia
    Mavroudis, Dimitris
    Stournaras, Christos
    Georgoulias, Vassilis
    CANCER RESEARCH, 2011, 71
  • [46] Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
    Aktas, Bahriye
    Kasimir-Bauer, Sabine
    Mueller, Volkmar
    Janni, Wolfgang
    Fehm, Tanja
    Wallwiener, Diethelm
    Pantel, Klaus
    Tewes, Mitra
    BMC CANCER, 2016, 16
  • [47] Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
    Aktas, B.
    Kasimir-Bauer, S.
    Mueller, V.
    Rack, B.
    Janni, W.
    Pantel, K.
    Fehm, T.
    Tewes, M.
    CANCER RESEARCH, 2013, 73
  • [48] Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
    Bahriye Aktas
    Sabine Kasimir-Bauer
    Volkmar Müller
    Wolfgang Janni
    Tanja Fehm
    Diethelm Wallwiener
    Klaus Pantel
    Mitra Tewes
    BMC Cancer, 16
  • [49] Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled analysis by HER2 and ER status.
    Twelves, Chris
    Cortes, Javier
    Vandat, Linda T.
    Olivo, Martin S.
    He, Yi
    Kaufman, Peter Andrew
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Correlation of Expression of HER2 in Circulating Tumor Cells and in Corresponding Primary Tumors in Breast Cancer Patients
    Harigopal, M.
    Galullo, P.
    Levy, G.
    Hui, P.
    Kowalski, D.
    Rimm, D. L.
    Chhieng, D.
    MODERN PATHOLOGY, 2011, 24 : 92A - 92A
12345